Investor Alert

New York Markets Close in:

Integra LifeSciences Holdings Corp.



Market open

 --Real time quotes

May 12, 2021, 1:29 p.m.





-0.57 -0.80%


Volume 236,687

Real time quotes


Previous close

$ 71.13

$ 70.56


-0.57 -0.80%

Day low

Day high




52 week low

52 week high




Annual Financials for Integra LifeSciences Holdings Corp.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 992.08M1.19B1.47B1.52B1.37B
Cost of Goods Sold (COGS) incl. D&A 344.08M427.46M558.09M612.54M566.95M
COGS excluding D&A 271.42M338.56M442.39M497.84M447.96M
Depreciation & Amortization Expense 72.67M88.9M115.7M114.7M118.99M
Depreciation 31.2M36.1M44.1M47.66M45.06M
Amortization of Intangibles 41.47M52.8M71.6M67.04M73.93M
Gross Income 647.99M760.78M914.35M905.02M804.92M
20162017201820192020 5-year trend
SG&A Expense 487.64M583.35M679.5M659.54M594.45M
Research & Development 57.96M63.46M78.04M33.08M30.87M
Other SG&A 429.69M519.9M601.46M626.46M563.58M
Other Operating Expense (300,000)----
Unusual Expense 53.09M132.24M124.64M149.22M80.8M
EBIT after Unusual Expense 107.57M45.19M110.21M96.26M129.67M
Non Operating Income/Expense 545,000887,00012.33M18.92M17.59M
Non-Operating Interest Income 24,000255,0002.8M1.15M1.69M
Equity in Affiliates (Pretax) -----
Interest Expense 17.73M34.94M67.94M56.23M55.43M
Gross Interest Expense 18.73M36.04M70.24M59.33M57.73M
Interest Capitalized 1M1.1M2.3M3.1M2.3M
Pretax Income 90.41M11.39M57.4M60.1M93.52M
Income Tax 15.84M(53.36M)(3.4M)9.9M(40.37M)
Income Tax - Current Domestic 16.2M7.88M(2.27M)18.04M11.21M
Income Tax - Current Foreign 6.11M6.07M7.06M10.91M12.55M
Income Tax - Deferred Domestic (5.15M)(67.22M)(10.25M)(11.56M)(6.84M)
Income Tax - Deferred Foreign (1.32M)(80,000)2.07M(7.49M)(57.3M)
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 74.56M64.74M60.8M50.2M133.89M
Minority Interest Expense -----
Net Income 74.56M64.74M60.8M50.2M133.89M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 74.56M64.74M60.8M50.2M133.89M
Preferred Dividends -----
Net Income Available to Common 74.56M64.74M60.8M50.2M133.89M
EPS (Basic) 1.000.840.730.591.58
Basic Shares Outstanding 74.39M76.9M82.86M85.64M84.65M
EPS (Diluted) 0.940.820.720.581.57
Diluted Shares Outstanding 79.19M79.12M84M86.49M85.23M
EBITDA 233.32M266.33M350.55M360.17M329.46M
Link to MarketWatch's Slice.